Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
2010
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis
2009
Quantum phase transition in a common metal
2002 Nature
Entanglement Entropy of theν = 1 / 2
2015 StandoutNobel
Gout and hyperuricemia
2002
Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review
2017
Gapless spin liquid of an organic triangular compound evidenced by thermodynamic measurements
2011
Gout-associated uric acid crystals activate the NALP3 inflammasome
2006 StandoutNature
The value of synovial fluid assays in the diagnosis of joint disease: a literature survey
2002
High-Pressure Sequence ofBa 3 NiSb 2 O 9 S = 1 Ni 2 +
2011 StandoutNobel
Unconventional Superconductivity with a Sign Reversal in the Order Parameter ofLaFeAsO 1 − x F x
2008 Standout
Sjögren's syndrome
2005 Standout
Synovial fluid analysis
2005
Quantum criticality
2005 Nature
Pathogenesis of ankylosing spondylitis and reactive arthritis
2005
Diagnosis of crystal-induced arthritis by synovial fluid examination for crystals: Lessons from an imperfect test
1999
Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3
2011
Competition between heavy fermion and Kondo interaction in isoelectronic A-site-ordered perovskites
2014 StandoutNobel
Juvenile idiopathic arthritis
2007 Standout
Critical Behavior of the Ferromagnetic PerovskiteBaRuO 3
2008 StandoutNobel
Critical Local-Moment Fluctuations, Anomalous Exponents, andω / T
2002
A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy
2004
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
2008 Standout
Is gout associated with reduced quality of life? A case-control study
2007
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
2007
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
2013
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout
2008
Gout
2009 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
2006
Thermodynamic Properties in the Approach to the Quantum Critical Point of the Spin-Ladder MaterialNa 2 Co 2 ( C 2 O 4 ) 3 ( H 2 O ) 2
2005
Pathogenesis of spondylarthropathies
1995
Multiferroic and magnetoelectric materials
2006 StandoutNature
The experience of pain and emergent osteoarthritis of the knee
2001
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
2008
Long-term safety of pegloticase in chronic gout refractory to conventional treatment
2012
Monosodium urate monohydrate crystal–induced inflammation in vivo: Quantitative histomorphometric analysis of cellular events
2002
Why is osteoarthritis an age-related disease?
2010
Recent developments in crystal-induced inflammation pathogenesis and management
2007
Enhancement of the Nernst effect by stripe order in a high-Tc superconductor
2009 StandoutNatureNobel
Ankylosing spondylitis
2007 Standout
Delayed examination of synovial fluid by ordinary and polarised light microscopy to detect and identify crystals
2002
Gout: Update on Some Pathogenic and Clinical Aspects
2006
Gout
2016 Standout
Mechanisms of inflammation in gout
2005
Developing a provisional definition of flare in patients with established gout
2011
Rheumatoid Arthritis: New Findings on the Failure to Isolate or Detect Mycoplasmas by Multiple Cultivation or Serologic Procedures and a Review of the Literature
1991
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Gout update: from lab to the clinic and back
2000
Gout in Solid Organ Transplantation
2005
Aspiration of normal or asymptomatic pathological joints for diagnosis and research: indications, technique and success rate
2008
Magnetic-Field-Induced Quantum Critical Point and Competing Order Parameters inU R u 2 S i 2
2003
Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout
2007
Yersinia Antigens in Synovial-Fluid Cells from Patients with Reactive Arthritis
1989
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Classification of inflammatory arthritis by enthesitis
1998
Risk factors for gout and prevention: a systematic review of the literature
2011
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout
2007
Pressure-Induced Non-Fermi-Liquid Behavior ofPrNiO 3
2005 StandoutNobel
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Unconventional superconductivity in magic-angle graphene superlattices
2018 StandoutNature
Magnetic metal–organic frameworks
2009 Standout
Osteoarthritis
2019 Standout
Infection and Arthritis
1994
Treating to target: a strategy to cure gout
2009
Induction of experimental allergic arthritis with outer surface proteins of borrelia burgdorferi
1994
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
2010
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose‐response clinical trial examining safety and efficacy in patients with gout
2005
Management of Acute and Chronic Gouty Arthritis
2004
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Inflammasomes in health and disease
2012 StandoutNature
Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 Inflammasome In Vitro
2011
Electronic structure calculations with dynamical mean-field theory
2006 Standout
Singular or non-Fermi liquids
2002
Electron scattering near an itinerant to localized electronic transition
2003 StandoutNobel
Histocompatibility typing in the rheumatic diseases. Diagnostic and prognostic implications.
1994
Transition from a weak ferromagnetic insulator to an exchange-enhanced paramagnetic metal in theBaIrO 3
2009 StandoutNobel
Pseudogap temperature T *
2018 StandoutNobel
Entanglement in many-body systems
2008 Standout
Is there more than one type of quantum critical points in heavy-fermion metals?
2001
Aging, Cellular Senescence, and Cancer
2012 Standout
Multichannel Anderson impurity behavior in a pure hybridization impurity model
2004
Cutting Edge: Inflammatory Signaling by Borrelia burgdorferi Lipoproteins Is Mediated by Toll-Like Receptor 2
1999 Standout
Non-Fermi-liquid and magnetic behaviour of the system
1996
Dynamical mean-field theory of strongly correlated fermion systems and the limit of infinite dimensions
1996 Standout
Quantum criticality in heavy-fermion metals
2008
The Pyroptotic Cell Death Effector Gasdermin D Is Activated by Gout-Associated Uric Acid Crystals but Is Dispensable for Cell Death and IL-1β Release
2019
Antiferromagnetic spin fluctuation and superconductivity
2003
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Pathogenesis of Gout
2005
Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual‐Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial
2019
The Inflammasomes: Guardians of the Body
2009 Standout
New observations concerning magnetism and superconductivity in heavy-fermion metals
1996
Gout
2021 Standout
VO: A strongly correlated metal close to a Mott-Hubbard transition
2007 StandoutNobel
Magnetically mediated superconductivity in heavy fermion compounds
1998 StandoutNature
Thermoelectric behavior near the magnetic quantum critical point
2001
Monosodium urate monohydrate crystallization
2011
Medication Adherence in Gout: A Systematic Review
2014
Lowering serum uric acid levels: What is the optimal target for improving clinical outcomes in gout?
2007
Non-Fermi-liquid behavior ind f
2001
Molecular Biology and Pathogenicity of Mycoplasmas
1998 Standout
Non-Fermi-Liquid Scaling of the Magnetic Response in UCu5 − x Pd x ( x = 1 , 1.5 )
1995
Linear temperature dependence of resistivity and change in the Fermi surface at the pseudogap critical point of a high-Tc superconductor
2008 StandoutNobel
Enhanced thermoelectric power near the quantum phase transition in the itinerant-electron ferromagnet MnSi
2010 StandoutNobel
Critical Fermi surfaces and non-Fermi liquid metals
2008
Superconductivity in iron compounds
2011 Standout
Global magnetic phase diagram and local quantum criticality in heavy fermion metals
2006
Mass enhancement versus Stoner enhancement in strongly correlated metallic perovskites:LaNiO 3 LaCuO 3
2014 StandoutNobel
Fermi-liquid instabilities at magnetic quantum phase transitions
2007 Standout
The local quantum critical point and non-Fermi liquid properties
2003
Synchrotron X-ray diffraction and absorption studies of CeM2X2 (M=Cu, Ni and X=Si, Ge) at high pressure
2005 StandoutNobel
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial
2008
Exchange bias in nanostructures
2005 Standout
The superconducting phases ofUPt 3
2002
Spin fluctuations in the antiferromagnetic metalNb 12 O 29
2009 StandoutNobel
Thermopower across the stripe critical point ofLa 1.6 − x Nd 0.4 Sr x CuO 4 T c
2009 StandoutNobel
Interplay of Disorder and Spin Fluctuations in the Resistivity near a Quantum Critical Point
1999
Local fluctuations in quantum critical metals
2003
Non-Fermi-liquid behavior near aT=0 spin-glass transition
1995
Works of M. Sieck being referenced
Intra‐articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch
2003
Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies
2002
Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model
1993
Light and electron microscopic studies on the synovial membrane in reiter's syndrome.
1988
A comparison of five preparations of synthetic monosodium urate monohydrate crystals.
1992
Development and evaluation of a method for preservation of synovial fluid wet preparations for quality control testing of crystal identification.
1990
Investigation of non-Fermi-liquid behavior in CeCu6−xAux
1996
Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
2001
Uniaxial pressure dependence of the Néel temperature in CeCu5.8Au0.2
1997
Reproducibility of synovial fluid analyses. A study among four laboratories
1986
The behavior of the heavy-fermion superconductor UPt3 under hydrostatic pressure and in a magnetic field
1995
Magnetic and thermodynamic properties CeCu6−xAux for 0 ≤ x ≤ 2
1994
Effect of a nonsteroidal antiinflammatory drug on synovial fluid in osteoarthritis.
1996
Non-Fermi-liquid behavior in a heavy-fermion alloy at a magnetic instability
1994
Magnetization and specific heat of CeCu6−xMx (MNi, Pd, Pt)
1996
Pressure dependence of the Néel temperature in antiferromagnetic CeCu6−xAux for 0.3 ⩽ x ⩽ 1.3
1995
Non-Fermi-liquid behavior in strongly correlated electron systems
1997